The literature reports that COVID-19 vaccination has altered the course of the pandemic and has saved millions of lives. The inadequate access to vaccines in the developing world and low-income countries has limited the impact of COVID-19 vaccinations reinforcing the need for global vaccine equity and coverage. The effectiveness, safety, cost and side effects by various vaccines has been questioned. A number of COVID-19 vaccines have been assessed in the first year of the COVID-19 epidemic. Researchers and companies may now support the best COVID-19 vaccine for the developing world and the global population.
RELEVANT REFERENCES:
A. Watson OJ, Barnsley G, Toor J, Hogan AB, Winskill P, Ghani AC. Global impact of the first year of COVID-19 vaccination: a mathematical modelling study. Lancet Infect Dis. 2022 Sep;22(9):1293-1302.
B. David A Henry, Mark A Jones, Paulina Stehlik, Paul P Glasziou, Effectiveness of COVID‐19 vaccines: findings from real‐world studies, Medical Journal of Australia, 10.5694/mja2.51479, 216, 8, (431-431), (2022).
C. COVID-19 Infection and Anti-Aging Gene Inactivation. Acta Scientific Nutritional Health 4.5 (2020): 01-02.
D. COVID-19 and Cardiovascular Disease in the Global Chronic Disease Epidemic. J Clin Med Res. 2022;4(1):1-2.